Relevant studies have demonstrated the efficient in vivo delivery of ALKBH5 mRNA to colorectal cancer cells using folic acid‐modified EVs‐liposome hybrid nanoparticles (FA‐ELNPs), significantly inhibiting the progression of colorectal cancer [103]. Here, ALKBH5 is linked to colorectal cancer.